TBPS[1]
|
|
|
|
| Names
|
Preferred IUPAC name
4-tert-Butyl-2,6,7-trioxa-1λ5-phosphabicyclo[2.2.2]octane-1-thione
|
| Identifiers
|
CAS Number
|
|
3D model (JSmol)
|
|
| ChEMBL
|
|
| ChemSpider
|
|
| KEGG
|
|
|
|
|
|
|
|
InChI=1S/C8H15O3PS/c1-7(2,3)8-4-9-12(13,10-5-8)11-6-8/h4-6H2,1-3H3 Key: VTBHBNXGFPTBJL-UHFFFAOYSA-N
|
CC(C)(C)C12COP(=S)(OC1)OC2
|
| Properties
|
Chemical formula
|
C8H15O3PS
|
| Molar mass
|
222.24 g·mol−1
|
| Hazards
|
| Occupational safety and health (OHS/OSH):
|
Main hazards
|
Extremely toxic
|
| Lethal dose or concentration (LD, LC):
|
|
|
53 μg/kg (mice)[2]
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
|
TBPS (tert-butylbicyclophosphorothionate) is a bicyclic phosphate convulsant.[3] It is an extremely potent GABA receptor antagonist.[4][5]
See also
References
- ^ "tert-Butyl bicyclo[2.2.2]phosphorothionate".
- ^ Milbrath, Dean S.; Engel, Judith L.; Verkade, John G.; Casida, John E. (February 1979). "Structure-toxicity relationships of 1-substituted-4-alkyl-2,6,7-trioxabicyclo[2.2.2.]octanes". Toxicology and Applied Pharmacology. 47 (2): 287–293. doi:10.1016/0041-008x(79)90323-5. PMID 452023.
- ^ Trifiletti, Rosario R; Snowman, Adele M; Snyder, Solomon H (1984). "Solubilization and anionic regulation of cerebral sedative and convulsant receptors labeled with [35S] tert-butylbicyclophosphorothionate (TBPS)". Biochemical and Biophysical Research Communications. 120 (2): 692–9. doi:10.1016/0006-291x(84)91311-1. PMID 6329179.
- ^ Atack, J R; Ohashi, Y; McKernan, R M (2009). "Characterization of [35S]t-butylbicyclophosphorothionate ([35S]TBPS) binding to GABAA receptors in postmortem human brain". British Journal of Pharmacology. 150 (8): 1066–74. doi:10.1038/sj.bjp.0707186. PMC 2013908. PMID 17339834.
- ^ Im, Wha Bin; Pregenzer, Jeffrey F; Thomsen, Darrel R (1994). "Effects of GABA and various allosteric ligands on TBPS binding to cloned rat GABAA receptor subtypes". British Journal of Pharmacology. 112 (4): 1025–30. doi:10.1111/j.1476-5381.1994.tb13185.x. PMC 1910256. PMID 7952860.
|
|---|
| Ionotropic | | GABAATooltip γ-Aminobutyric acid A receptor |
- Positive modulators (abridged; see here for a full list): α-EMTBL
- Alcohols (e.g., drinking alcohol, 2M2B)
- Anabolic steroids
- Avermectins (e.g., ivermectin)
- Barbiturates (e.g., phenobarbital)
- Benzodiazepines (e.g., diazepam)
- Bromide compounds (e.g., potassium bromide)
- Carbamates (e.g., meprobamate)
- Carbamazepine
- Chloralose
- Chlormezanone
- Clomethiazole
- Dihydroergolines (e.g., ergoloid (dihydroergotoxine))
- Etazepine
- Etifoxine
- Fenamates (e.g., mefenamic acid)
- Flavonoids (e.g., apigenin, hispidulin)
- Fluoxetine
- Flupirtine
- Imidazoles (e.g., etomidate)
- Kava constituents (e.g., kavain)
- Lanthanum
- Loreclezole
- Monastrol
- Neuroactive steroids (e.g., allopregnanolone, cholesterol, THDOC)
- Niacin
- Niacinamide
- Nonbenzodiazepines (e.g., β-carbolines (e.g., abecarnil), cyclopyrrolones (e.g., zopiclone), imidazopyridines (e.g., zolpidem), pyrazolopyrimidines (e.g., zaleplon))
- Norfluoxetine
- Petrichloral
- Phenols (e.g., propofol)
- Phenytoin
- Piperidinediones (e.g., glutethimide)
- Propanidid
- Pyrazolopyridines (e.g., etazolate)
- Quinazolinones (e.g., methaqualone)
- Retigabine (ezogabine)
- ROD-188
- Skullcap constituents (e.g., baicalin)
- Stiripentol
- Sulfonylalkanes (e.g., sulfonmethane (sulfonal))
- Topiramate
- Valerian constituents (e.g., valerenic acid)
- Volatiles/gases (e.g., chloral hydrate, chloroform, diethyl ether, paraldehyde, sevoflurane)
- Negative modulators: 1,3M1B
- 3M2B
- 11-Ketoprogesterone
- 17-Phenylandrostenol
- α3IA
- α5IA (LS-193,268)
- β-CCB
- β-CCE
- β-CCM
- β-CCP
- β-EMGBL
- Anabolic steroids
- Amiloride
- Anisatin
- β-Lactams (e.g., penicillins, cephalosporins, carbapenems)
- Basmisanil
- Bemegride
- Bicyclic phosphates (, TBPO, IPTBO)
- BIDN
- Bilobalide
- Bupropion
- CHEB
- Chlorophenylsilatrane
- Cicutoxin
- Cloflubicyne
- Cyclothiazide
- DHEA
- DHEA-S
- Dieldrin
- (+)-DMBB
- DMCM
- DMPC
- EBOB
- Etbicyphat
- FG-7142 (ZK-31906)
- Fiproles (e.g., fipronil)
- Flavonoids (e.g., amentoflavone, oroxylin A)
- Flumazenil
- Fluoroquinolones (e.g., ciprofloxacin)
- Flurothyl
- Furosemide
- Golexanolone
- Iomazenil (123I)
- IPTBO
- Isopregnanolone (sepranolone)
- L-655,708
- Laudanosine
- Lindane
- MaxiPost
- Morphine
- Morphine-3-glucuronide
- MRK-016
- Naloxone
- Naltrexone
- Nicardipine
- Nonsteroidal antiandrogens (e.g., apalutamide, bicalutamide, enzalutamide, flutamide, nilutamide)
- Oenanthotoxin
- Pentylenetetrazol (pentetrazol)
- Phenylsilatrane
- Picrotoxin (i.e., picrotin, picrotoxinin and dihydropicrotoxinin)
- Pregnenolone sulfate
- Propybicyphat
- PWZ-029
- Radequinil
- Ro 15-4513
- Ro 19-4603
- RO4882224
- RO4938581
- Sarmazenil
- SCS
- Suritozole
- TB-21007
- TBOB
- TCS-1105
- Terbequinil
- TETS
- Thujone
- U-93631
- Zinc
- ZK-93426
|
|---|
| GABAA-ρTooltip γ-Aminobutyric acid A-rho receptor | |
|---|
|
|---|
| Metabotropic | | GABABTooltip γ-Aminobutyric acid B receptor |
- Negative modulators: Compound 14
|
|---|
|
|---|
- See also
- Receptor/signaling modulators
- GABAA receptor positive modulators
- GABA metabolism/transport modulators
|
|
|---|
| GABA receptor antagonists | |
|---|
| GABA synthesis inhibitors |
- 3-Mercaptopropionic acid
- 4-Deoxypyridoxine
- Allylglycine
- Crimidine
- Decaborane
- Ginkgotoxin
- Isoniazid
- Pentaborane
- Thiocarbohydrazide
- Toxopyrimidine
|
|---|
| Glycine receptor antagonists | |
|---|
| Glutamate receptor agonists | |
|---|
| Convulsant barbiturates |
- CHEB
- Diberal (DMBB)
- McN-481
|
|---|
| Other |
- 2,2,3,3-Tetrafluoropropyl trifluoromethyl ether
- Bromocamphor
- Camphor
- FAZ-4
- Fluoroethyl fluoroacetate
- MC-2973
- Methionine sulfoximine
- Methyl fluoroacetate
- Nitrocyclohexane
- Thebaine
|
|---|